RKT, which enhances ghrelin signaling through GHS-R, partly alleviated ghrelin resistance and ameliorated cachexia symptoms, such as anorexia and body weight loss, without affecting elevated plasma ghrelin in the model. This evidence concerns the gene GHRL and Cachexia.